Related Experiment Video

Updated: Jun 29, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Chronic hepatitis C: genotypes 4 to 9

Mindie H Nguyen1, Emmet B Keeffe

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. mindiehn@stanford.edu

Clinics in Liver Disease
|July 19, 2005
PubMed

Insights

Hepatitis C virus (HCV) genotypes 4-9, though less studied, may differ in epidemiology, clinical presentation, and treatment outcomes compared to more common HCV genotypes 1-3. This review explores these potential distinctions.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) genotypes 1, 2, and 3 are globally prevalent and extensively studied.
  • HCV genotypes 4-9 are endemic in specific regions, with significant disease burden (e.g., 18% prevalence of HCV genotype 4 in Egypt).
  • Limited research exists on the distinct characteristics of chronic hepatitis C caused by less common HCV genotypes.

Purpose of the Study:

  • To review existing literature on hepatitis C virus (HCV) genotypes 4-9.
  • To explore potential epidemiologic, clinical, and treatment outcome differences between HCV genotypes 4-9 and genotypes 1-3.

Main Methods:

  • Systematic review of published literature.
  • Analysis of studies focusing on HCV genotypes 4 through 9.
  • Comparison of findings with data from studies on HCV genotypes 1, 2, and 3.

Main Results:

  • HCV genotypes 4-9 may present unique epidemiologic patterns.
  • Clinical manifestations of chronic hepatitis C might differ across HCV genotypes.
  • Treatment outcomes for chronic hepatitis C could vary based on the infecting HCV genotype.

Conclusions:

  • Hepatitis C virus (HCV) genotypes 4-9 warrant further investigation due to potential differences from common genotypes.
  • Understanding these distinctions is crucial for accurate diagnosis, effective management, and targeted treatment strategies for chronic hepatitis C.
  • Future research should focus on the specific epidemiology, clinical course, and therapeutic responses associated with HCV genotypes 4-9.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...